These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15259070)

  • 21. In vitro transcriptional activation of p21 promoter by p53.
    Kim TK
    Biochem Biophys Res Commun; 1997 May; 234(2):300-2. PubMed ID: 9177263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thioredoxin-dependent redox regulation of p53-mediated p21 activation.
    Ueno M; Masutani H; Arai RJ; Yamauchi A; Hirota K; Sakai T; Inamoto T; Yamaoka Y; Yodoi J; Nikaido T
    J Biol Chem; 1999 Dec; 274(50):35809-15. PubMed ID: 10585464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1.
    De Siervi A; Marinissen M; Diggs J; Wang XF; Pages G; Senderowicz A
    Cancer Res; 2004 Jan; 64(2):743-50. PubMed ID: 14744793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.
    Polyak SJ; Khabar KS; Paschal DM; Ezelle HJ; Duverlie G; Barber GN; Levy DE; Mukaida N; Gretch DR
    J Virol; 2001 Jul; 75(13):6095-106. PubMed ID: 11390611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
    Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
    Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.
    Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB
    J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
    Torgeman A; Mor-Vaknin N; Zelin E; Ben-Aroya Z; Löchelt M; Flügel RM; Aboud M
    Virology; 2001 Mar; 281(1):10-20. PubMed ID: 11222091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21.
    Yin Y; Zhu A; Jin YJ; Liu YX; Zhang X; Hopkins KM; Lieberman HB
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8864-9. PubMed ID: 15184659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between transactivation domain of p53 and middle part of TBP-like protein (TLP) is involved in TLP-stimulated and p53-activated transcription from the p21 upstream promoter.
    Maeda R; Suzuki H; Tanaka Y; Tamura TA
    PLoS One; 2014; 9(3):e90190. PubMed ID: 24594805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.
    Zhu WG; Srinivasan K; Dai Z; Duan W; Druhan LJ; Ding H; Yee L; Villalona-Calero MA; Plass C; Otterson GA
    Mol Cell Biol; 2003 Jun; 23(12):4056-65. PubMed ID: 12773551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
    Liang SX; Richardson DR
    Carcinogenesis; 2003 Oct; 24(10):1601-14. PubMed ID: 12869419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53.
    Resnick-Silverman L; St Clair S; Maurer M; Zhao K; Manfredi JJ
    Genes Dev; 1998 Jul; 12(14):2102-7. PubMed ID: 9679054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.